ACTRN12606000404527
Completed
Phase 3
A randomised placebo-controlled trial of testosterone undecanoate in obese men as adjuvant therapy for a weight loss program
The Woolcock Institute of Medical Research0 sites60 target enrollmentSeptember 14, 2006
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Obstructive Sleep Apnea (OSA)
- Sponsor
- The Woolcock Institute of Medical Research
- Enrollment
- 60
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •No significant uncontrolled medical problems.
Exclusion Criteria
- •Severe OSA ((minimum oxygen saturation \< 65% or RDI \> 80\) requiring immediate treatment due to severity or increased associated risk (eg Transport worker), Use of drugs that alter androgen action, Contraindications to testosterone therapy, Desire for paternity within the next 12 months, Participation in sports that ban testosterone and require drug monitoring, Psychiatric disorders or drug abuse unless well controlled,Chronic medical conditions likely to interfere with or influence study treatment or safety unless well controlled.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
Testosterone therapy for the treatment of nonalcoholic fatty liver diseaseACTRN12619000701123Austin Health120
Completed
Phase 4
Testosterone for gender dysphoria in transgender meTransgender healthGender dysphoriaDepressionSuicideMetabolic and Endocrine - Other endocrine disordersMental Health - DepressionMental Health - SuicideACTRN12621000716864niversity of Melbourne64
Active, not recruiting
Phase 1
Does Testposterone improve the Pain Perception of Patients with Chronic Pain?Patient with persistent somatoform pain disorder (F45.40 or F45.41) should be included into the study.Therapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03]EUCTR2016-000048-32-DERWTH Aachen University/CTC-A60
Completed
Not Applicable
A randomised controlled trial of intravenous steroids at home versus outpatients department for treatment of acute multiple sclerosis relapseservous System Diseases: Multiple sclerosis (MS)Nervous System DiseasesISRCTN95588376Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)164
Completed
Not Applicable
The PROOF trial: PROtecting Ovaries and Fertility during chemotherapyISRCTN96797814Ottawa Hospital Research Institute (OHRI) (Canada) - formerly Ottawa Health Research Institute30